Advertisement
UK markets closed
  • FTSE 100

    8,076.04
    +35.66 (+0.44%)
     
  • FTSE 250

    19,591.61
    -127.76 (-0.65%)
     
  • AIM

    753.15
    -1.54 (-0.20%)
     
  • GBP/EUR

    1.1656
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2497
    +0.0034 (+0.28%)
     
  • Bitcoin GBP

    51,085.87
    -787.11 (-1.52%)
     
  • CMC Crypto 200

    1,376.35
    -6.22 (-0.45%)
     
  • S&P 500

    5,012.76
    -58.87 (-1.16%)
     
  • DOW

    37,879.93
    -580.99 (-1.51%)
     
  • CRUDE OIL

    82.25
    -0.56 (-0.68%)
     
  • GOLD FUTURES

    2,346.60
    +8.20 (+0.35%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,924.96
    -163.74 (-0.91%)
     
  • CAC 40

    8,018.90
    -72.96 (-0.90%)
     

Why These Biotechs Diverged On AnaptysBio's Peanut Allergy Study

Why These Biotechs Diverged On AnaptysBio's Peanut Allergy Study

AnaptysBio dipped Tuesday despite trial results showing its peanut-allergy drug improved symptoms in nearly half of adult patients tested.